Clinical Trial

Exploring Pathogenesis and Treatment of Hypercalcemia Caused by Intramuscular Injection of Paraffinoil

Recruiting
View on ClinicalTrials.gov →
Summary
The aim of the study is to characterize paraffin oil induced granulomatous disease. We will investigate pathogenesis and natural history of paraffin disease. Subsequently, through further translational studies, we intend to identify novel treatments to be tested in future randomized clinical trials.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2020-02-10; most recent amendment 2024-09-30.
Trial Details
NCT Number NCT04265599
Lead Sponsor Herlev Hospital
Conditions Hypercalcemia, Renal Injury, Paraffinoma
Enrollment 200 participants
Start Date 2019-04-30
Primary Completion 2027-01-31 (estimated)
Study Completion 2027-01-31 (estimated)
Updated on ClinicalTrials.gov 2024-10-01